Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Iscience|June 26, 2023
What the BTBR/J mouse has taught us about diabetes and diabetic complicationsMark P Keller, Kelly L Hudkins, Anath Shalev, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2021
PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric HypoglycemiaColleen M Craig, Helen Margaret Lawler, Clare Jung Eun Lee, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 24, 2015
Cholecystokinin expression in the β-cell leads to increased β-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosisJeremy A Lavine, Carly R Kibbe, Mieke Baan, et al.
Metabolites|December 23, 2022
Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of InflammationRachel J Fenske, Alicia M Weeks, Michael Daniels, et al.
Molecular Endocrinology (Baltimore, Md.)|October 11, 2008
Overexpression of pre-pro-cholecystokinin stimulates beta-cell proliferation in mouse and human islets with retention of islet functionJeremy A Lavine, Philipp W Raess, Dawn Belt Davis, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 13, 2024
The prostaglandin E2 EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesityJoshua C Neuman, Austin Reuter, Kathryn A Carbajal, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 18, 2013
Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 β-cell lineKimberly A Krautkramer, Amelia K Linnemann, Danielle A Fontaine, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 6, 2021
Cholecystokinin attenuates β-cell apoptosis in both mouse and human isletsHung Tae Kim, Arnaldo H Desouza, Heidi Umhoefer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 14, 2023
Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical CohortBenjamin Wancewicz, Yanlong Zhu, Rachel J Fenske, et al.
Molecular Endocrinology (Baltimore, Md.)|July 28, 2010
FoxM1 is up-regulated by obesity and stimulates beta-cell proliferationDawn Belt Davis, Jeremy A Lavine, Joshua I Suhonen, et al.
Pageof 4